Multimodality treatment for patients with hepatocellular carcinoma: A single institution retrospective series

European Journal of Surgical Oncology

Volumn 26, Issue 1, 2000, Pages 67-72

  Takano, S ^a   Watanabe, Y ^a   Ohishi, H ^a   Kono, S ^a   Nakamura, M ^a   Kubota, N ^a   Iwai, S ^a  

^a NIHON UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

Hepatic resection; Hepatocellular carcinoma; Percutaneous ethanol injection therapy; Regional chemotherapy; Transcatheter arterial embolization

Indexed keywords

ALCOHOL; ANTINEOPLASTIC AGENT; DOXORUBICIN; EPIRUBICIN; IODINATED POPPYSEED OIL;

ADULT; AGED; ARTICLE; ARTIFICIAL EMBOLISM; CANCER STAGING; CANCER SURVIVAL; FEMALE; HUMAN; LIVER CELL CARCINOMA; LIVER FUNCTION; LIVER RESECTION; MAJOR CLINICAL STUDY; MALE; MULTIMODALITY CANCER THERAPY; PRACTICE GUIDELINE; PRIORITY JOURNAL; RETROSPECTIVE STUDY; TREATMENT OUTCOME; TUMOR VOLUME;

EID: 0033983097     PISSN: 07487983     EISSN: None     Source Type: Journal    
DOI: 10.1053/ejso.1999.0743     Document Type: Article

References (30)

1. Ryu M, Shimamura Y, Kinoshita T. Therapeutic results of resection, transcatheter arterial embolization and percutaneous transhepatic ethanol injection in 3225 patients with hepatocellular carcinoma: a retrospective multicenter study. Jpn J Clin Oncol. 27:1997;251-257.
2. Lise M, Bachetti S, Pian PD. Prognostic factor affecting long term outcome after liver resection for hepatocellular carcinoma. Cancer. 82:1998;1028-1036.
3. UICC International Union Against Cancer. TNM classification of malignant tumours. 4th edNew York: Springer-Verlag. 1987;53-56.
4. Fujio N, Sakai K, Kinoshita H. Results of treatment of patients with hepatocellular carcinoma with severe cirrhosis of the liver. World J Surg. 13:1989;211-218.
5. Ngan H, Lai CL, Fan ST. Treatment of inoperable hepatocellular carcinoma by transcatheter arterial chemoembolization using an emulsion of cisplatin in iodized oil and Gelfoam. Clin Radiol. 47:1993;315-320.
6. Ikeda K, Saitoh S, Tsubota A. Risk factors for tumor recurrence and prognosis after curative resection of hepatocellular carcinoma. Cancer. 71:1993;19-25.
7. Ono T, Nagasue N, Kohno H. Adjuvant chemotherapy with epirubicin and carmofur after radical resection of hepatocellular carcinoma: a prospective randomized study. Semin Oncol. 24 (Suppl. 6):1997;18-25.
8. Lai ECS, Lo CM, Fan ST, Liu CL, Wong J. Postoperative adjuvant chemotherapy after curative resection of hepatocellular carcinoma: a randomized controlled trial. Arch Surg. 133:1998;183-188.
9. Minoyama A, Yoshikawa M, Ebara M. Study of repeated arterial infusion chemotherapy with a subcutaneously implanted reservoir for advanced hepatocellular carcinoma. J Gastroenterol. 30:1995;356-366.
10. Nakamura K, Takahashi S, Takada K. Clinical evaluation of intermittent arterial infusion chemotherapy with an implanted reservoir for hepatocellular carcinoma. Cancer Chemother Pharmacol. 31 (Suppl. I):1992;S93-8.
11. Matsui O, Kadoya M, Yoshikawa J. Subsegmental transcatheter arterial embolization for small hepatocellular carcinomas: local therapeutic effect and 5-year survival rate. Cancer Chemother Pharmacol. 33 (Suppl. I):1994;S84-8.
12. Nakamura H, Oi N, Hori S. Outcome of localized hepatocellular carcinoma treated with segmental arterioportal chemoembolization. Cancer Chemother Pharmacol. 31 (Suppl. I):1992;S69-71.
13. Shiina S, Tagawa K, Unuma T. Percutaneous ethanol injection therapy of hepatocellular carcinoma: analysis of 77 patients. Am J Roentgenol. 155:1990;1221-1226.
14. Tanikawa K, Majima Y. Percutaneous ethanol injection therapy for recurrent hepatocellular carcinoma. Hepatogastroenterology. 40:1993;324-327.
15. Kawasaki S, Makuuchi M, Miyagawa S. Results of hepatic resection for hepatocellular carcinoma. World J Surg. 19:1995;31-34.
16. Sheen PC, Lee KT, Chen HY. Conservative hepatic resection for hepatocellular carcinoma of cirrhotic patients. Int Surg. 81:1996;280-283.
17. Paquet KJ, Koussourie P, Mercade MA. Limited hepatic resection for selected cirrhotic patients with hepatocellular carcinoma: a prospective study. Br J Surg. 78:1991;459-462.
18. Kosuge T, Makuuchi M, Takayama T. Long-term results after resection of hepatocellular carcinoma: experience of 480 cases. Hepatogastroenterology. 40:1993;333-336.
19. Lee PH, Lin WJ, Tsang YM. Clinical management of recurrent hepatocellular carcinoma. Ann Surg. 222:1995;670-676.
20. Group d'Etude et de Traitement du Carcinome Hepatocellulaire. A comparison of lipiodol chemoembolization and conservative treatment for unresectable hepatocellular carcinoma. N Engl J Med. 332:1995;1256-1261.
21. Castells A, Bruix J, Bru C. Treatment of small hepatocellular carcinoma in cirrhotic patients: a cohort study comparing surgical resection and percutaneous ethanol injection. Hepatology. 18:1993;1121-1126.
22. Poon RTP, Fan ST, Lo CM. Intrahepatic recurrence after curative resection of hepatocellular carcinoma: long-term results of treatment and prognostic factors. Ann Surg. 226:1999;216-222.
23. Nakao N, Kamio K, Miura K. Recurrent hepatocellular carcinoma after partial hepatectomy: value of treatment with transcatheter arterial chemoembolization. Am J Roentgenol. 156:1991;1177-1179.
24. Takayasu K, Wakao F, Moriyama N. Postresection recurrence of hepatocellular carcinoma treated by arterial embolization: analysis of prognostic factors. Hepatology. 16:1992;906-911.
25. Furuta T, Kanematsu T, Matsumata T. Lipiodolization prolongs survival rates in postoperative recurrent hepatocellular carcinoma. Hepatogastroenterology. 37:1991;494-497.
26. Kakazu T, Makuuchi M, Kawasaki S. Repeat hepatic resection for recurrent hepatocellular carcinoma. Hepatogastroenterology. 40:1993;337-341.
27. Zhou XD, Yu YQ, Tang ZY. Surgical treatment of recurrent hepatocellular carcinoma. Hepatogastroenterology. 40:1993;333-336.
28. Nagasue N, Kohno H, Hayashi T. Repeat hepatectomy for recurrent hepatocellular carcinoma. Br J Surg. 83:1996;127-131.
29. Yamamoto K, Masuzawa M, Kato M. Analysis of prognostic factors in patients with hepatocellular carcinoma treated by transcatheter arterial embolization. Cancer Chemother Pharmacol. 21 (Suppl. I):1992;S77-81.
30. Okazaki M, Yamasaki S, Ono H. Chemoembolotherapy for recurrent hepatocellular carcinoma in the residual liver after hepatectomy. Hepatogastroenterology. 40:1993;320-323.